Licensing Partnerships 3B has a history of licensing and collaboration deals with Clovis Oncology and Debiopharm, and recent activity with RefleXion, indicating openness to co development and licensing partnerships for radiopharmaceuticals and diagnostics.

Radiopharma Collaborations The RefleXion licensing for SCINTIX suggests opportunities to supply radiopharmaceuticals, support joint development, or forge distribution deals with imaging and radiotherapy platform players.

EU Expansion Based in Berlin with European partnerships and a moderate workforce, there is potential to pursue regulatory, market access, and clinical trial services to expand 3B's footprint across the EU.

Manufacturing & CDMO A path to growth lies in GMP manufacturing, process development, and analytical services to scale radioligand programs or diagnostics for partner companies seeking reliable supply chains.

Leadership Signals Leadership changes, including the CMO departure, may reflect strategic pivot opportunities for business development teams to engage in clinical development, regulatory strategy, and program management partnerships.